Literature DB >> 31864827

Safety and efficiency of endoscopic resection versus laparoscopic resection in gastric gastrointestinal stromal tumours: A systematic review and meta-analysis.

Chao Wang1, Zhidong Gao2, Kai Shen3, Jian Cao3, Zhanlong Shen1, Kewei Jiang4, Shan Wang5, Yingjiang Ye6.   

Abstract

The application of endoscopic resection (ER) in gastric gastrointestinal stromal tumours (GIST) is controversial. We carried out a meta-analysis to compare the safety and efficiency of ER with laparoscopic resection (LR) in patients with gastric GISTs. We searched PubMed to identify studies comparing ER with LR in GIST. The outcomes focused on two areas: safety, including operation time, blood loss, length of hospital stay, time to flatus, time to liquid, time to soft diet, and postoperative complications; and efficiency, including positive margin, recurrence, and long-term survival. A total of 1292 patients from 12 studies were included in the meta-analysis. Patients undergoing ER had a shorter operation time (standardised mean difference [SMD] -1.48, 95% confidence interval [CI] -2.18 to -0.78) and shorter time to soft diet (SMD -1.02, 95% CI -1.52 to -0.52) than those undergoing LR. No significant differences were observed between the groups in terms of blood loss, length of hospital stay, time to flatus, time to liquid, and postoperative complications. ER was also associated with greater positive margins compared with LR (relative risk 6.32, 95% CI 1.41-28.26). There were no significant differences between ER and LR for recurrence and 5-year disease-free survival. The limited evidence suggests that ER is a more effective strategy for improving postoperative recovery without increasing the risk of surgery and recurrence in gastric GIST. However, close attention should be paid to margin status after ER.
Copyright © 2019 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Entities:  

Keywords:  Endoscopic resection; Gastric GIST; Laparoscopic resection; Meta-analysis

Mesh:

Year:  2019        PMID: 31864827     DOI: 10.1016/j.ejso.2019.10.030

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  8 in total

1.  Endoscopic or Surgical Resection for Patients with 2-5cm Gastric Gastrointestinal Stromal Tumors: A Single-Center 12-Year Experience from China.

Authors:  Tianxiang Lei; Fengbo Tan; Heli Liu; Miao Ouyang; Haiyan Zhou; Peng Liu; Xianhui Zhao; Bin Li
Journal:  Cancer Manag Res       Date:  2020-08-24       Impact factor: 3.989

2.  Seropositive Reaction Rates of 9 B-Cell Epitopes of the SARS-CoV-2 Spike Protein and the Relationship between the Epitopes and Neutralizing Antibody.

Authors:  Li Zhu; Yunwen Zhang; Zhengrong Yang; Baisheng Li; Tiejian Feng; Xuan Zou; Jianfan He; Taiping He; Junling Li; Ning Liu; Wei Li; Xiaohui Wang
Journal:  Intervirology       Date:  2021-07-07       Impact factor: 1.763

3.  Comparison Among Endoscopic, Laparoscopic, and Open Resection for Relatively Small Gastric Gastrointestinal Stromal Tumors (<5 cm): A Bayesian Network Meta-Analysis.

Authors:  Zhen Liu; Ziyang Zeng; Siwen Ouyang; Zimu Zhang; Juan Sun; Xianze Wang; Xin Ye; Weiming Kang; Jianchun Yu
Journal:  Front Oncol       Date:  2021-11-29       Impact factor: 6.244

4.  Surgical Resection Is Still Better Than Endoscopic Resection for Patients With 2-5 cm Gastric Gastrointestinal Stromal Tumours: A Propensity Score Matching Analysis.

Authors:  Hao Wu; Han Li; Qinfeng Xu; Liang Shang; Ronghua Zhang; Chen Li; Mengdi Fu; Wandi Xu; Jianfeng Chen; Jin Liu; Leping Li
Journal:  Front Oncol       Date:  2021-09-15       Impact factor: 6.244

5.  Open and minimally invasive surgery for gastrointestinal stromal tumours: a systematic review and network meta-analysis protocol.

Authors:  Mingchun Mu; Zhaolun Cai; Chunyu Liu; Chaoyong Shen; Yuan Yin; Xiaonan Yin; Zhiyuan Jiang; Zhou Zhao; Bo Zhang
Journal:  BMJ Open       Date:  2022-02-07       Impact factor: 2.692

Review 6.  Exposed endoscopic full-thickness resection for duodenal submucosal tumors: Current status and future perspectives.

Authors:  Antonino Granata; Alberto Martino; Francesco Paolo Zito; Dario Ligresti; Michele Amata; Giovanni Lombardi; Mario Traina
Journal:  World J Gastrointest Endosc       Date:  2022-02-16

7.  Human neutralising antibodies elicited by SARS-CoV-2 non-D614G variants offer cross-protection against the SARS-CoV-2 D614G variant.

Authors:  Cheryl Yi-Pin Lee; Siti Naqiah Amrun; Rhonda Sin-Ling Chee; Yun Shan Goh; Tze-Minn Mak; Sophie Octavia; Nicholas Kim-Wah Yeo; Zi Wei Chang; Matthew Zirui Tay; Anthony Torres-Ruesta; Guillaume Carissimo; Chek Meng Poh; Siew-Wai Fong; Wang Bei; Sandy Lee; Barnaby Edward Young; Seow-Yen Tan; Yee-Sin Leo; David C Lye; Raymond Tp Lin; Sebastien Maurer-Stroh; Bernett Lee; Cheng-I Wang; Laurent Renia; Lisa Fp Ng
Journal:  Clin Transl Immunology       Date:  2021-02-22

Review 8.  Efficacy and safety of endoscopic resection in treatment of small gastric stromal tumors: A state-of-the-art review.

Authors:  Ze-Ming Chen; Min-Si Peng; Li-Sheng Wang; Zheng-Lei Xu
Journal:  World J Gastrointest Oncol       Date:  2021-06-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.